The use of famotidine in the treatment of Parkinson's disease: a pilot study

S. P. Molinari; R. Kaminski; A. Di Rocco; M. D. Yahr

doi:10.1007/BF02259665

The use of famotidine in the treatment of Parkinson's disease: a pilot study

S. P. Molinari
, R. Kaminski
, A. Di Rocco
, M. D. Yahr

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Abstract

Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia. Patients received famotidine 80 mg/day for a period of six weeks and were evaluated with neuropsychological tests. Overall, patients demonstrated improvement in variables measured. Some patients also reported an improvement in their motor symptoms.

Original language	English
Pages (from-to)	243-247
Number of pages	5
Journal	Journal of Neural Transmission - Parkinson's Disease and Dementia Section
Volume	9
Issue number	2-3
DOIs	https://doi.org/10.1007/BF02259665
State	Published - Jun 1995
Externally published	Yes

Keywords

Famotidine
Parkinson's disease
bradyphrenia

Access to Document

10.1007/BF02259665

Cite this

@article{b53c3fd54cc54b948dd6b54dd8261cdc,

title = "The use of famotidine in the treatment of Parkinson's disease: a pilot study",

abstract = "Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia. Patients received famotidine 80 mg/day for a period of six weeks and were evaluated with neuropsychological tests. Overall, patients demonstrated improvement in variables measured. Some patients also reported an improvement in their motor symptoms.",

keywords = "Famotidine, Parkinson's disease, bradyphrenia",

author = "Molinari, \{S. P.\} and R. Kaminski and \{Di Rocco\}, A. and Yahr, \{M. D.\}",

year = "1995",

month = jun,

doi = "10.1007/BF02259665",

language = "English",

volume = "9",

pages = "243--247",

journal = "Journal of Neural Transmission - Parkinson's Disease and Dementia Section",

issn = "0936-3076",

publisher = "Springer Verlag",

number = "2-3",

}

TY - JOUR

T1 - The use of famotidine in the treatment of Parkinson's disease

T2 - a pilot study

AU - Molinari, S. P.

AU - Kaminski, R.

AU - Di Rocco, A.

AU - Yahr, M. D.

PY - 1995/6

Y1 - 1995/6

N2 - Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia. Patients received famotidine 80 mg/day for a period of six weeks and were evaluated with neuropsychological tests. Overall, patients demonstrated improvement in variables measured. Some patients also reported an improvement in their motor symptoms.

AB - Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia. Patients received famotidine 80 mg/day for a period of six weeks and were evaluated with neuropsychological tests. Overall, patients demonstrated improvement in variables measured. Some patients also reported an improvement in their motor symptoms.

KW - Famotidine

KW - Parkinson's disease

KW - bradyphrenia

UR - https://www.scopus.com/pages/publications/0029165295

U2 - 10.1007/BF02259665

DO - 10.1007/BF02259665

M3 - Article

C2 - 8527008

AN - SCOPUS:0029165295

SN - 0936-3076

VL - 9

SP - 243

EP - 247

JO - Journal of Neural Transmission - Parkinson's Disease and Dementia Section

JF - Journal of Neural Transmission - Parkinson's Disease and Dementia Section

IS - 2-3

ER -

The use of famotidine in the treatment of Parkinson's disease: a pilot study

Abstract

Keywords

Access to Document

Fingerprint

Cite this